Hope for BET inhibition in patients with leukaemia or lymphoma
- PMID: 27063970
- DOI: 10.1016/S2352-3026(15)00253-7
Hope for BET inhibition in patients with leukaemia or lymphoma
Comment on
-
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study.Lancet Haematol. 2016 Apr;3(4):e186-95. doi: 10.1016/S2352-3026(15)00247-1. Epub 2016 Mar 18. Lancet Haematol. 2016. PMID: 27063977 Clinical Trial.
-
Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study.Lancet Haematol. 2016 Apr;3(4):e196-204. doi: 10.1016/S2352-3026(16)00021-1. Epub 2016 Mar 18. Lancet Haematol. 2016. PMID: 27063978 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical